First Niagara Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$329K Hold
2,500
0.09% 144
2016
Q1
$347K Hold
2,500
0.1% 139
2015
Q4
$349K Sell
2,500
-2,882
-54% -$397K 0.1% 139
2015
Q3
$753K Sell
5,382
-21
-0.4% -$3.16K 0.2% 105
2015
Q2
$887K Buy
5,403
+21
+0.4% +$3.35K 0.2% 102
2015
Q1
$831K Sell
5,382
-1,000
-16% -$142K 0.18% 109
2014
Q4
$802K Hold
6,382
0.17% 111
2014
Q3
$764K Hold
6,382
0.16% 116
2014
Q2
$687K Hold
6,382
0.14% 125
2014
Q1
$636K Sell
6,382
-380
-6% -$34.4K 0.13% 131
2013
Q4
$625K Buy
6,762
+50
+0.7% +$4.44K 0.12% 139
2013
Q3
$561K Hold
6,712
0.12% 141
2013
Q2
$550K Buy
+6,712
New +$502K 0.12% 142

Other funds holding ELV

First Niagara Bank's ELV Position: Q2 2016 in Review

First Niagara Bank held its Elevance Health (ELV) position steady in Q2 2016 at 2,500 shares worth $329K. The position accounts for 0.09% of the portfolio, ranked #144.

First Niagara Bank first reported a position in ELV in Q2 2013 and has held it in 13 quarters since. The position peaked at $887K in Q2 2015. 760 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

  • First Niagara Bank held 2,500 shares of Elevance Health worth $329K as of Q2 2016.
  • First Niagara Bank left its Elevance Health share count unchanged in Q2 2016.
  • Elevance Health made up 0.09% of First Niagara Bank's portfolio in Q2 2016, its #144 holding.
  • First Niagara Bank first reported a position in Elevance Health in Q2 2013 and has held it in 13 quarters since.
  • First Niagara Bank's Elevance Health position peaked at $887K in Q2 2015.
  • 760 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.